{"entity":{"type":"insider","cik":"0001791058","url":"/insider/0001791058","json_url":"/insider/0001791058.json","name":"Swayze Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":24,"first":"2021-01-06","last":"2026-06-26","span_basis":"filed_date"},"name_variants":[{"name":"Swayze Eric","source":"filing","n_filings":24,"first_seen":"2021-01-06","last_seen":"2026-06-26"}],"transactions":[{"id":6145515,"accession":"0000874015-26-000211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-26-000211","line_url":"/filing/0000874015-26-000211#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10602.0,"shares_display":"10,602","price_per_share":79.1824,"price_display":"79.18","price_state":"stated","total_value":839491.8048,"total_display":"839,491.80","total_whole":"839,492","shares_owned_after":21759.0,"shares_owned_after_display":"21,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-26","scope":"insider"},{"id":5901144,"accession":"0000874015-26-000111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000111","line_url":"/filing/0000874015-26-000111","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15642.0,"shares_display":"15,642","price_per_share":81.76153661296509,"price_display":"81.76","price_state":"stated","total_value":1278913.9557,"total_display":"1,278,913.96","total_whole":"1,278,914","shares_owned_after":38312.0,"shares_owned_after_display":"38,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-13","scope":"insider","n_lines":2},{"id":6145512,"accession":"0000874015-26-000102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000102","line_url":"/filing/0000874015-26-000102#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6179.0,"shares_display":"6,179","price_per_share":82.9335,"price_display":"82.93","price_state":"stated","total_value":512446.0965,"total_display":"512,446.10","total_whole":"512,446","shares_owned_after":47747.0,"shares_owned_after_display":"47,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":5914541,"accession":"0000874015-26-000072","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-26-000072","line_url":"/filing/0000874015-26-000072","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9933.0,"shares_display":"9,933","price_per_share":75.34310782241015,"price_display":"75.34","price_state":"stated","total_value":748383.09,"total_display":"748,383.09","total_whole":"748,383","shares_owned_after":41935.0,"shares_owned_after_display":"41,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider","n_lines":2},{"id":5891542,"accession":"0000874015-26-000026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-26-000026","line_url":"/filing/0000874015-26-000026","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23463.0,"shares_display":"23,463","price_per_share":79.11709968887185,"price_display":"79.12","price_state":"stated","total_value":1856324.51,"total_display":"1,856,324.51","total_whole":"1,856,325","shares_owned_after":30453.0,"shares_owned_after_display":"30,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider","n_lines":2},{"id":4656505,"accession":"0000874015-25-000262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000262","line_url":"/filing/0000874015-25-000262#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53.0,"shares_display":"53","price_per_share":73.6213,"price_display":"73.62","price_state":"stated","total_value":3901.9289,"total_display":"3,901.93","total_whole":"3,902","shares_owned_after":256.0,"shares_owned_after_display":"256","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-16","scope":"insider"},{"id":5020829,"accession":"0000874015-25-000254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000254","line_url":"/filing/0000874015-25-000254#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6849.0,"shares_display":"6,849","price_per_share":69.02,"price_display":"69.02","price_state":"stated","total_value":472717.98,"total_display":"472,717.98","total_whole":"472,718","shares_owned_after":30453.0,"shares_owned_after_display":"30,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider"},{"id":4336535,"accession":"0000874015-25-000245","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-25-000245","line_url":"/filing/0000874015-25-000245#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12972.0,"shares_display":"12,972","price_per_share":66.2259,"price_display":"66.23","price_state":"stated","total_value":859082.3748,"total_display":"859,082.37","total_whole":"859,082","shares_owned_after":37302.0,"shares_owned_after_display":"37,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-02","scope":"insider"},{"id":4336526,"accession":"0000874015-25-000245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000245","line_url":"/filing/0000874015-25-000245#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14142.0,"shares_display":"14,142","price_per_share":66.0912,"price_display":"66.09","price_state":"stated","total_value":934661.7504,"total_display":"934,661.75","total_whole":"934,662","shares_owned_after":37302.0,"shares_owned_after_display":"37,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-02","scope":"insider"},{"id":4903515,"accession":"0000874015-25-000224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000224","line_url":"/filing/0000874015-25-000224","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11130.0,"shares_display":"11,130","price_per_share":49.673106648697214,"price_display":"49.67","price_state":"stated","total_value":552861.677,"total_display":"552,861.68","total_whole":"552,862","shares_owned_after":38432.0,"shares_owned_after_display":"38,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider","n_lines":2},{"id":4336512,"accession":"0000874015-25-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000081","line_url":"/filing/0000874015-25-000081#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1367.0,"shares_display":"1,367","price_per_share":32.3058,"price_display":"32.31","price_state":"stated","total_value":44162.0286,"total_display":"44,162.03","total_whole":"44,162","shares_owned_after":48017.0,"shares_owned_after_display":"48,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-03","scope":"insider"},{"id":5020804,"accession":"0000874015-25-000065","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-25-000065","line_url":"/filing/0000874015-25-000065","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7176.0,"shares_display":"7,176","price_per_share":32.8425615942029,"price_display":"32.84","price_state":"stated","total_value":235678.222,"total_display":"235,678.22","total_whole":"235,678","shares_owned_after":45670.0,"shares_owned_after_display":"45,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider","n_lines":2},{"id":2941152,"accession":"0000874015-24-000241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000241","line_url":"/filing/0000874015-24-000241#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1194.0,"shares_display":"1,194","price_per_share":37.921,"price_display":"37.92","price_state":"stated","total_value":45277.674,"total_display":"45,277.67","total_whole":"45,278","shares_owned_after":33713.0,"shares_owned_after_display":"33,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-14","scope":"insider"},{"id":2267348,"accession":"0000874015-24-000229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000229","line_url":"/filing/0000874015-24-000229#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53.0,"shares_display":"53","price_per_share":38.313,"price_display":"38.31","price_state":"stated","total_value":2030.589,"total_display":"2,030.59","total_whole":"2,031","shares_owned_after":157.0,"shares_owned_after_display":"157","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-17","scope":"insider"},{"id":9201495,"accession":"0000874015-24-000196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000196","line_url":"/filing/0000874015-24-000196#line-1","is_derivative":false,"issuer_cik":"0001791058","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0001791058","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1940.0,"shares_display":"1,940","price_per_share":49.5613,"price_display":"49.56","price_state":"stated","total_value":96148.922,"total_display":"96,148.92","total_whole":"96,149","shares_owned_after":34291.0,"shares_owned_after_display":"34,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-09-04","scope":"insider"},{"id":2299307,"accession":"0000874015-24-000110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000874015-24-000110","line_url":"/filing/0000874015-24-000110#line-3","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1907.0,"shares_display":"1,907","price_per_share":49.5613,"price_display":"49.56","price_state":"stated","total_value":94513.3991,"total_display":"94,513.40","total_whole":"94,513","shares_owned_after":34324.0,"shares_owned_after_display":"34,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-02","scope":"insider"},{"id":2299303,"accession":"0000874015-24-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000110","line_url":"/filing/0000874015-24-000110#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10773.0,"shares_display":"10,773","price_per_share":52.0,"price_display":"52.00","price_state":"stated","total_value":560196.0,"total_display":"560,196.00","total_whole":"560,196","shares_owned_after":32516.0,"shares_owned_after_display":"32,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":2169939,"accession":"0000874015-24-000078","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-24-000078","line_url":"/filing/0000874015-24-000078","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6305.0,"shares_display":"6,305","price_per_share":50.417,"price_display":"50.42","price_state":"stated","total_value":317879.185,"total_display":"317,879.18","total_whole":"317,879","shares_owned_after":43289.0,"shares_owned_after_display":"43,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-18","scope":"insider","n_lines":2},{"id":2670511,"accession":"0000874015-24-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000006","line_url":"/filing/0000874015-24-000006#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27100.0,"shares_display":"27,100","price_per_share":50.1875,"price_display":"50.19","price_state":"stated","total_value":1360081.25,"total_display":"1,360,081.25","total_whole":"1,360,081","shares_owned_after":32516.0,"shares_owned_after_display":"32,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-28","filed_date":"2024-01-02","scope":"insider"},{"id":8456317,"accession":"0000874015-23-000203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000203","line_url":"/filing/0000874015-23-000203#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52.0,"shares_display":"52","price_per_share":47.949,"price_display":"47.95","price_state":"stated","total_value":2493.348,"total_display":"2,493.35","total_whole":"2,493","shares_owned_after":73.0,"shares_owned_after_display":"73","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-10-18","scope":"insider"},{"id":8100159,"accession":"0000874015-23-000096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000096","line_url":"/filing/0000874015-23-000096#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":40.7886,"price_display":"40.79","price_state":"stated","total_value":74031.309,"total_display":"74,031.31","total_whole":"74,031","shares_owned_after":31941.0,"shares_owned_after_display":"31,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-07","scope":"insider"},{"id":8134507,"accession":"0000874015-23-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000069","line_url":"/filing/0000874015-23-000069#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5631.0,"shares_display":"5,631","price_per_share":39.7442,"price_display":"39.74","price_state":"stated","total_value":223799.5902,"total_display":"223,799.59","total_whole":"223,800","shares_owned_after":30041.0,"shares_owned_after_display":"30,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":6234316,"accession":"0000874015-22-000157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-22-000157","line_url":"/filing/0000874015-22-000157#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":460.0,"shares_display":"460","price_per_share":44.55,"price_display":"44.55","price_state":"stated","total_value":20493.0,"total_display":"20,493.00","total_whole":"20,493","shares_owned_after":19892.0,"shares_owned_after_display":"19,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"},{"id":6690661,"accession":"0000874015-22-000149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-22-000149","line_url":"/filing/0000874015-22-000149#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":45.2,"price_display":"45.20","price_state":"stated","total_value":45.2,"total_display":"45.20","total_whole":"45","shares_owned_after":20352.0,"shares_owned_after_display":"20,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider"},{"id":6712893,"accession":"0000874015-22-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-22-000101","line_url":"/filing/0000874015-22-000101#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP Research)","role_mark":"O","role_mark_label":"Officer (EVP Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":378.0,"shares_display":"378","price_per_share":44.15,"price_display":"44.15","price_state":"stated","total_value":16688.7,"total_display":"16,688.70","total_whole":"16,689","shares_owned_after":20353.0,"shares_owned_after_display":"20,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-25","scope":"insider"},{"id":4161394,"accession":"0000874015-21-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-21-000019","line_url":"/filing/0000874015-21-000019#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791058","owner_name":"Swayze Eric","owner_display_name":"Swayze Eric","owner_url":"/insider/0001791058","role":"Officer (EVP, Research)","role_mark":"O","role_mark_label":"Officer (EVP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195.0,"shares_display":"195","price_per_share":55.99,"price_display":"55.99","price_state":"stated","total_value":10918.05,"total_display":"10,918.05","total_whole":"10,918","shares_owned_after":5107.0,"shares_owned_after_display":"5,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Officer (EVP Research)","n_filings":24,"first_seen":"2021-01-06","last_seen":"2026-06-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001791058","retrieved_at":"2026-08-24T01:01:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}